Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Is Nvidia Stock a Buy in Advance of Q2 Earnings?

By Louis Navellier and the InvestorPlace Research Staff
Nvidia is set to report Q2 earnings on Aug. 18, and a big factor that will impact NVDA stock after will be the global chip shortage.

Don’t Be Afraid to Buy the Dip in Pinterest Stock

By Louis Navellier and the InvestorPlace Research Staff
Pinterest shows strong revenue growth, but the market is punishing it for a drop in monthly average users. Don't be fearful of PINS stock.

7 Unstoppable Stocks to Buy to Power Up Your Portfolio

By Joel Baglole, InvestorPlace Contributor
These stocks to buy can provide investors with big and consistent returns as they continue to defy expectations and soar to new heights.

DraftKings’ Q2 Earnings Show the Stock May Be Worth $80-Plus

By Mark R. Hake, CFA
DraftKings' Q2 sales and earnings surprise analysts, pushing up its inherent value. DKNG stock could be worth 56% more at $80.93, assuming it achieves 2025 revenue and margin targets.

7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught

By Josh Enomoto, InvestorPlace Contributor
You may have thought the moment of relevancy for these biotech stocks was over, but the Delta variant has changed their prospects.

3 Speculative Stocks Worth Rolling the Dice on in August

By Joel Baglole, InvestorPlace Contributor
Speculative stocks are inherently risky and investors who buy them are gambling with their money. But these companies could be worth the bet.

Why Panicking Out of Uber Last Week Was Wrong

By Nicolas Chahine, InvestorPlace Contributor
The UBER stock thesis is long term. Short-term action can get crazy but it is now consolidating to build a base in the middle of its range.

If You Can Buy Novavax Stock at Around $200, It’s a Great Long Term Bet

By Will Ashworth, InvestorPlace Contributor
Good news keeps rolling in for Novavax. However, for NVAX stock to return to $300, it needs a little help from Wall Street analysts.

5 Retail Stocks to Buy Ahead of Strong Back-to-School Sales

By Faizan Farooque, InvestorPlace Contributor
Back-to-school retail stocks are one of the more interesting ways to play the reopening trend after more than a year of virtual learning.

Senseonics Could Go Higher, Especially if It Nabs FDA Approval

By Mark R. Hake, CFA
Senseonics looks interesting here, especially with possible FDA approval. SENS stock is worth about 24% more at over $4, or even $6-plus once its CGM rolls out.

Novavax Is Looking More Like a Bet Worth Taking

By Alex Sirois, InvestorPlace Contributor
NVAX stock fell behind other vaccine plays early in 2021, but it might not stay behind, There's lots of evidence to suggest it could move soon

Corsair Gaming Stock Has Hit Its Stride at the Right Time and Place

By Alex Sirois, InvestorPlace Contributor
CRSR stock looks like a strong performer on a burgeoning e-sports and gaming landscape. Investors should consider after it posted strong growth recently.

Nio Stock Presents an Excellent Buying Opportunity as EVs Go Global

By Ian Cooper, InvestorPlace Contributor
Nio (NYSE:NIO) stock is still one of the hottest electric vehicle plays. The last time I offered my opinion on the stock, I said I’d…

3 Reasons To Buy SHOP Stock Even After Its Post-Earnings Dip

By Vandita Jadeja
Shopify looks attractive after Q2 earnings and it is investing aggressively to attract merchants. SHOP stock has a long way to go.

4 Top Stock Trades for Wednesday: AMD, APPS, FSR, MU

By Bret Kenwell, InvestorPlace Contributor
Advanced Micro Devices, Digital Turbine, Fisker and Micron were our top stock trades for Wednesday. Now, let's look at how the charts set up.

3 EV Stocks to Buy to Make a Fortune

By Luke Lango, InvestorPlace Senior Investment Analyst
To find the winners in the EV revolution, you need to go through the following checklist, and make sure the company checks off every single one of these boxes.

The Delta Variant Is a Shot in the Arm for Vaxart’s Pill Vaccine

By Mark R. Hake, CFA
The Delta Covid variant gives Vaxart new life with its oral vaccine and could boost VRXT stock. VXRT stock is worth over 30% more at $13.00 if its Covid pill works, according to sell-side analysts.

7 Consumer Discretionary Stocks to Buy That Are Booking Record Profits

By Will Ashworth, InvestorPlace Contributor
All kinds of companies have been reporting record profits in recent weeks. Here are seven of the best consumer discretionary stocks to buy.

Canopy Growth’s U.S. Journey Has Not Begun

By Nicolas Chahine, InvestorPlace Contributor
CGC stock is off its game but the long-term prospects are still viable. The cannabis thesis hasn't even yet officially started in the U.S.
Load More Articles